首页 产品目录 分子砌块 按反应类型 1,2,4-三唑 (15S,18S,27S)-27-氨基-3-((1-(((S)-1-((S)-2-(((5S,8S,11S,14S)-5-((S)-2-(((S)-5-氨基-1-(((S)-4-氨基-1-(((S)-1-(((S)-3-氨基-1-羧基-3-氧代丙基)氨基)-1-氧代丙烷-2-基)氨基)-1,4-二氧代丁烷-2-基)氨基)-1,5-二氧代戊烷-2-基)氨基甲酰基)吡咯烷-1-羰基)-15-(1H-咪唑-5-基)-11-异丙基-8-甲氧基-7,10,13-三氧代-2-硫杂-6,9,12-三氮杂十五烷-14-基)氨基甲酰基)吡咯烷-1-基)-5-胍基-1-氧代戊烷-2-基)氨基)-3-(1H-咪唑-5-基)-1-氧代丙烷-2-基)氨基甲酰基)-9-(2-羧乙基)-15-(羧甲基)-6-(3-胍基丙基)-18,21-双(羟甲基)-12-异丁基-24-(2-(甲硫基)乙基)-5,8,11,14,17,20,23,26-八氧代-4,7,10,13,16,19,22,25-八氮杂壬二十九烷二酸

(15S,18S,27S)-27-氨基-3-((1-(((S)-1-((S)-2-(((5S,8S,11S,14S)-5-((S)-2-(((S)-5-氨基-1-(((S)-4-氨基-1-(((S)-1-(((S)-3-氨基-1-羧基-3-氧代丙基)氨基)-1-氧代丙烷-2-基)氨基)-1,4-二氧代丁烷-2-基)氨基)-1,5-二氧代戊烷-2-基)氨基甲酰基)吡咯烷-1-羰基)-15-(1H-咪唑-5-基)-11-异丙基-8-甲氧基-7,10,13-三氧代-2-硫杂-6,9,12-三氮杂十五烷-14-基)氨基甲酰基)吡咯烷-1-基)-5-胍基-1-氧代戊烷-2-基)氨基)-3-(1H-咪唑-5-基)-1-氧代丙烷-2-基)氨基甲酰基)-9-(2-羧乙基)-15-(羧甲基)-6-(3-胍基丙基)-18,21-双(羟甲基)-12-异丁基-24-(2-(甲硫基)乙基)-5,8,11,14,17,20,23,26-八氧代-4,7,10,13,16,19,22,25-八氮杂壬二十九烷二酸

(15S,18S,27S)-27-amino-3-((1-(((S)-1-((S)-2-(((5S,8S,11S,14S)-5-((S)-2-(((S)-5-amino-1-(((S)-4-amino-1-(((S)-1-(((S)-3-amino-1-carboxy-3-oxopropyl)amino)-1-oxopropan-2-yl)amino)-1,4-dioxobutan-2-yl)amino)-1,5-dioxopentan-2-yl)carbamoyl)pyrrolidine-1-carbonyl)-15-(1H-imidazol-5-yl)-11-isopropyl-8-methoxy-7,10,13-trioxo-2-thia-6,9,12-triazapentadecan-14-yl)carbamoyl)pyrrolidin-1-yl)-5-guanidino-1-oxopentan-2-yl)amino)-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl)carbamoyl)-9-(2-carboxyethyl)-15-(carboxymethyl)-6-(3-guanidinopropyl)-18,21-bis(hydroxymethyl)-12-isobutyl-24-(2-(methylthio)ethyl)-5,8,11,14,17,20,23,26-octaoxo-4,7,10,13,16,19,22,25-octaazanonacosanedioic acid

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

85916-47-8

中文名称

(15S,18S,27S)-27-氨基-3-((1-(((S)-1-((S)-2-(((5S,8S,11S,14S)-5-((S)-2-(((S)-5-氨基-1-(((S)-4-氨基-1-(((S)-1-(((S)-3-氨基-1-羧基-3-氧代丙基)氨基)-1-氧代丙烷-2-基)氨基)-1,4-二氧代丁烷-2-基)氨基)-1,5-二氧代戊烷-2-基)氨基甲酰基)吡咯烷-1-羰基)-15-(1H-咪唑-5-基)-11-异丙基-8-甲氧基-7,10,13-三氧代-2-硫杂-6,9,12-三氮杂十五烷-14-基)氨基甲酰基)吡咯烷-1-基)-5-胍基-1-氧代戊烷-2-基)氨基)-3-(1H-咪唑-5-基)-1-氧代丙烷-2-基)氨基甲酰基)-9-(2-羧乙基)-15-(羧甲基)-6-(3-胍基丙基)-18,21-双(羟甲基)-12-异丁基-24-(2-(甲硫基)乙基)-5,8,11,14,17,20,23,26-八氧代-4,7,10,13,16,19,22,25-八氮杂壬二十九烷二酸

英文名称

(15S,18S,27S)-27-amino-3-((1-(((S)-1-((S)-2-(((5S,8S,11S,14S)-5-((S)-2-(((S)-5-amino-1-(((S)-4-amino-1-(((S)-1-(((S)-3-amino-1-carboxy-3-oxopropyl)amino)-1-oxopropan-2-yl)amino)-1,4-dioxobutan-2-yl)amino)-1,5-dioxopentan-2-yl)carbamoyl)pyrrolidine-1-carbonyl)-15-(1H-imidazol-5-yl)-11-isopropyl-8-methoxy-7,10,13-trioxo-2-thia-6,9,12-triazapentadecan-14-yl)carbamoyl)pyrrolidin-1-yl)-5-guanidino-1-oxopentan-2-yl)amino)-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl)carbamoyl)-9-(2-carboxyethyl)-15-(carboxymethyl)-6-(3-guanidinopropyl)-18,21-bis(hydroxymethyl)-12-isobutyl-24-(2-(methylthio)ethyl)-5,8,11,14,17,20,23,26-octaoxo-4,7,10,13,16,19,22,25-octaazanonacosanedioic acid

别名

KATACALCIN;KATACALCIN (HUMAN);C-PROCALCITONIN;C-PROCALCITONIN (HUMAN);CALCITONIN C-TERMINAL FLANKING PEPTIDE (HUMAN);DMSSDLERDHRPHVSMPQNAN;H-ASP-MET-SER-SER-ASP-LEU-GLU-ARG-ASP-HIS-ARG-PRO-HIS-VAL-SER-MET-PRO-GLN-ASN-ALA-ASN-OH;ASP-MET-SER-SER-ASP-LEU-GLU-ARG-ASP-HIS-ARG-PRO-HIS-VAL-SER-MET-PRO-GLN-ASN-ALA-ASN

标准英文名

(15S,18S,27S)-27-amino-3-((1-(((S)-1-((S)-2-(((5S,8S,11S,14S)-5-((S)-2-(((S)-5-amino-1-(((S)-4-amino-1-(((S)-1-(((S)-3-amino-1-carboxy-3-oxopropyl)amino)-1-oxopropan-2-yl)amino)-1,4-dioxobutan-2-yl)amino)-1,5-dioxopentan-2-yl)carbamoyl)pyrrolidine-1-carbonyl)-15-(1H-imidazol-5-yl)-11-isopropyl-8-methoxy-7,10,13-trioxo-2-thia-6,9,12-triazapentadecan-14-yl)carbamoyl)pyrrolidin-1-yl)-5-guanidino-1-oxopentan-2-yl)amino)-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl)carbamoyl)-9-(2-carboxyethyl)-15-(carboxymethyl)-6-(3-guanidinopropyl)-18,21-bis(hydroxymethyl)-12-isobutyl-24-(2-(methylthio)ethyl)-5,8,11,14,17,20,23,26-octaoxo-4,7,10,13,16,19,22,25-octaazanonacosanedioic acid

MDL No.

MFCD00133425

分子式

C97H154N34O36S2

分子量

2436.64

精确分子量

2435.07

SMILES

CO[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)C(CC1=CN=CN1)NC(=O)C(CC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)C(CO)NC(=O)C(CCSC)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)O

标准SMILES

C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)C(CC1=CN=CN1)NC(=O)C(CC(O)=O)NC(=O)C(CCCNC(N)=N)NC(=O)C(CCC(O)=O)NC(=O)C(CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)C(CO)NC(=O)C(CCSC)NC(=O)[C@@H](N)CC(O)=O)C(C)C)OC)C(=O)N[C@@H](CC(N)=O)C(O)=O

用途

Katacalcin is a potent peptide hormone with hypocalcemic activity, causing a rapid but transient reduction in blood calcium and phosphate levels by promoting their incorporation into bone; it inhibits fMLP-induced chemotaxis of CD14+ peripheral blood mononuclear cells (PBMCs) more potently than calcitonin (CT) or procalcitonin (PCT); it deactivates CD14+ PBMC chemotaxis not only toward N-formyl-Met-Leu-Phe (fMLP) but also toward other chemokine family attractants, PCT, CT, and itself (homologous and heterologous deactivation); it elicits concentration-dependent migration of CD14+ PBMCs across a wide concentration range (from attomolar to micromolar); and it regulates human CD14+ PBMC migration via protein kinase A-dependent cAMP signaling pathways.

InChIKey

BOARIOLZPFSAQJ-NQSKQZERSA-N

安全信息

SureRoute逆合成路线

1.  85916-47-8 逆合成路线 1

—
—
ACKYFI148
85916-47-8
来源: SureRoute

2.  85916-47-8 逆合成路线 2

—
—
ACKYFI148
85916-47-8
来源: SureRoute

3.  85916-47-8 逆合成路线 3

—
—
ACKYFI148
85916-47-8
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手